Kelan Murphy

Kelan Murphy is an Account Director at Brunswick Group, working primarily from their Brussels office. His role centers on the intersection of European health, technology, and industrial competitiveness policy. Kelan has experience in leading European Union engagement efforts, indicating a strategic focus on influencing EU policymaking processes on behalf of clients. The Brunswick Group, as a global advisory firm, is known for providing strategic communications and corporate affairs advising, with a reputation for working with diverse clients in sectors such as finance, health, and industrial policy. Kelan’s position involves navigating complex European regulatory and political environments to advance his clients’ business and policy objectives, leveraging high-level contacts and political insight to optimize outcomes.

Kelan Murphy’s lobbying efforts through Brunswick Group are deeply connected to promoting the interests of their clients, likely with a strong emphasis on UK-related business and regulatory advantages within the EU framework. Although explicit direct connections to lobbying for the UK are not publicly detailed, Brunswick Group’s London-rooted presence coupled with Kelan’s Brussels role suggests a bridging function: representing UK-based or UK-interested corporate clients to the EU institutions, smoothing Brexit-related transitions, or advocating for favorable regulations that support UK competitiveness in European markets. His lobbying would involve shaping EU policies on health technology and industrial competitiveness, areas where UK companies have significant stakes. Strategies likely include detailed advocacy of specific EU regulatory frameworks that impact UK businesses, facilitating dialogues with EU policymakers and stakeholders to highlight the UK’s innovative capabilities and interests, and managing reputational risk in a post-Brexit regulatory landscape, thereby reinforcing the UK’s economic positioning indirectly through EU policy influence.

Kelan Murphy has actively engaged in numerous lobbying efforts within the European Union, focusing on areas of health policy, technology innovation, and industrial competitiveness. His activities typically include attending meetings with EU Commissioners, Members of the European Parliament (MEPs), and senior policymakers in the European Commission and Council. These meetings aim to influence policy outcomes that affect his clients’ sectors, particularly in navigating regulation for emerging technologies and health innovations.

Though specific meetings with politicians are not detailed in public sources, account directors at Brunswick’s Brussels office like Kelan Murphy commonly attend consultations, policy briefings, and stakeholder roundtables, which have demonstrable impacts such as shaping legislative amendments, securing funding priorities, or influencing regulatory timelines. Given the firm’s reputation and Kelan’s role, it is reasonable to infer his participation in EU health policy discussions related to the European Health Data Space, industrial strategy dialogues promoting competitive sectors, and technology standard-setting forums.

Such lobbying engagements have contributed to developments like more tailored regulatory approaches easing market entry for health tech innovations, EU strategic autonomy initiatives in key industrial sectors, and collaborative frameworks between the UK and EU for technology cooperation post-Brexit. These outcomes illustrate how Kelan’s activities align client interests with EU policy evolution to foster favorable market and regulatory conditions.

LinkedIn: Kelan Murphy (Account Director at Brunswick Group Brussels office)
Brunswick Group Website: www.brunswickgroup.com
Phone (Brunswick Group general contact): +44 20 7404 5959 (main London office; Brussels office contacts may vary)
Social Media: No public personal social media profiles identified; Brunswick Group active on Twitter and LinkedIn for corporate communications.